Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Baynes, K. C.
Right arrow Articles by Feher, M. D
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Prevalence and management of hyperglycaemia in patients given thrombolysis for acute coronary syndromes

Kevin Cr Baynes

Beta Cell Diabetes Centre, Chelsea & Westminster Hospital, London, SW10 9NH, UK, kevin.baynes{at}gstt.sthames.nhs.uk

Colin Mcintosh

Beta Cell Diabetes Centre, Chelsea & Westminster Hospital, London, SW10 9NH, UK

Michael D Feher

Beta Cell Diabetes Centre, Chelsea & Westminster Hospital, London, SW10 9NH, UK

The prevalence of hyperglycaemia in patients given thrombolysis for suspected acute myocardial infarction has not been clearly established. This is a retrospective case-note study of 69 consecutive patients who received thrombolysis on admission to a coronary care unit over a 15-month period. Admission plasma glucose > 7.8 mmol/L was observed in 46%, whilst a random glucose > 11.0 mmol/L was recorded in 22% of the group. A history of type 2 diabetes was present in 19%; with a glucose > 11.0 mmol/L being recorded in 61% on admission. Intravenous insulin therapy was administered to 43% of those without a history of diabetes, but presentation hyperglycaemia in the diabetic range, whereas 88% of known diabetic patients were treated with insulin.

Hyperglycaemia/glucose intolerance, although commonly observed in patients thrombolysed for acute myocardial infarction, is not always managed with insulin therapy. There is a need for clear diabetes management protocols for all teams managing patients in coronary care units.

Key Words: acute coronary syndrome • diabetes mellitus • insulin therapy.

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 5, 346-348 (2003)
DOI: 10.1177/14746514030030050601


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
M W Savage, P M Mah, A P Weetman, and J Newell-Price
Endocrine emergencies
Postgrad. Med. J., September 1, 2004; 80(947): 506 - 515.
[Abstract] [Full Text] [PDF]